For the first time, research shows that a type 2 diabetes drug significantly reduces hospitalizations and death from heart failure. At the end of the trial period, investigators found that patients treated with the drug experienced reductions in blood sugar and blood pressure, as well as weight loss, compared to those on placebo. They also found major significant reductions in hospitalizations for heart failure (35%); the combined result for heart failure hospitalization or dying from heart disease (34%); and the combined result for being hospitalized or dying from heart failure (39%).
from Today's Healthcare News -- ScienceDaily http://ift.tt/1MwhQns
No comments:
Post a Comment